➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Dow
Mallinckrodt
Colorcon
AstraZeneca

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Lidocaine Hydrochloride And Epinephrine, and when can generic versions of Lidocaine Hydrochloride And Epinephrine launch?

Lidocaine Hydrochloride And Epinephrine is a drug marketed by Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, and Empi. and is included in thirteen NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Drug patent expirations by year for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
St. Joseph's Healthcare HamiltonPhase 2
CMC Ambroise ParéN/A
University of MinnesotaPhase 4

See all LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE clinical trials

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belmora Llc LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080504-004 Oct 19, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 088571-001 Sep 13, 1985 AP RX No No   Start Trial   Start Trial   Start Trial
Eastman Kodak LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 040057-001 Feb 26, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 078772-001 May 12, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089645-001 Jun 21, 1988 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
AstraZeneca
Dow
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.